Literature DB >> 16530336

Androgen excess in women--a health hazard?

Roland Rosmond1.   

Abstract

A significant body of evidence suggests that androgens in women may play a role in the genesis of central adiposity and type 2 diabetes. There are two principal sources of circulating androgens in females: the ovary and the adrenal gland. In hyperandrogenic women, there are elevated serum concentrations of androstenedione and testosterone and, in up to 50% of the women, dehydroepiandrosterone sulfate (DHEAS). The androgen precursor DHEAS is of exclusive adrenal origin, suggesting that hyperandrogenic women have an elevated proportion of adrenal androgen production and secretion. Another cause of androgen excess in reproductive-age women is a decreased conversion of testosterone to estradiol by the aromatase enzyme complex. In this review, we will discuss the hypothesized clinical sequel of elevated androgens in women - an aspect of women's health highly neglected. Furthermore, an attempt is made to appreciate what causes the androgens to initially rise from normal levels, allowing the onset of pathophysiological processes towards diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16530336     DOI: 10.1016/j.mehy.2005.09.057

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Eating behaviour and body image in overweight adolescent girls with or without hyperandrogenicity.

Authors:  M Askelöf; M Halldin Stenlid; B Edlund
Journal:  Eat Weight Disord       Date:  2007-03       Impact factor: 4.652

2.  Trends in overweight and obesity over 22 years in a large adult population: the HUNT Study, Norway.

Authors:  K Midthjell; C M Y Lee; A Langhammer; S Krokstad; T L Holmen; K Hveem; S Colagiuri; J Holmen
Journal:  Clin Obes       Date:  2013-03-19

Review 3.  Androgens in pregnancy: roles in parturition.

Authors:  Sofia Makieva; Philippa T K Saunders; Jane E Norman
Journal:  Hum Reprod Update       Date:  2014-03-18       Impact factor: 15.610

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.